1. Home
  2. RGEN vs PEGA Comparison

RGEN vs PEGA Comparison

Compare RGEN & PEGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • PEGA
  • Stock Information
  • Founded
  • RGEN 1981
  • PEGA 1983
  • Country
  • RGEN United States
  • PEGA United States
  • Employees
  • RGEN N/A
  • PEGA N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • PEGA EDP Services
  • Sector
  • RGEN Health Care
  • PEGA Technology
  • Exchange
  • RGEN Nasdaq
  • PEGA Nasdaq
  • Market Cap
  • RGEN 8.0B
  • PEGA 7.8B
  • IPO Year
  • RGEN N/A
  • PEGA 1996
  • Fundamental
  • Price
  • RGEN $128.04
  • PEGA $97.83
  • Analyst Decision
  • RGEN Buy
  • PEGA Buy
  • Analyst Count
  • RGEN 12
  • PEGA 13
  • Target Price
  • RGEN $172.67
  • PEGA $100.38
  • AVG Volume (30 Days)
  • RGEN 830.2K
  • PEGA 1.0M
  • Earning Date
  • RGEN 04-29-2025
  • PEGA 04-22-2025
  • Dividend Yield
  • RGEN N/A
  • PEGA 0.12%
  • EPS Growth
  • RGEN N/A
  • PEGA 156.48
  • EPS
  • RGEN N/A
  • PEGA 2.14
  • Revenue
  • RGEN $650,429,000.00
  • PEGA $1,642,666,000.00
  • Revenue This Year
  • RGEN $13.93
  • PEGA $9.61
  • Revenue Next Year
  • RGEN $14.35
  • PEGA $6.09
  • P/E Ratio
  • RGEN N/A
  • PEGA $45.77
  • Revenue Growth
  • RGEN 4.88
  • PEGA 14.29
  • 52 Week Low
  • RGEN $102.97
  • PEGA $55.71
  • 52 Week High
  • RGEN $182.52
  • PEGA $113.67
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.98
  • PEGA 73.68
  • Support Level
  • RGEN $123.10
  • PEGA $92.42
  • Resistance Level
  • RGEN $135.47
  • PEGA $95.67
  • Average True Range (ATR)
  • RGEN 6.85
  • PEGA 2.35
  • MACD
  • RGEN -0.74
  • PEGA 0.63
  • Stochastic Oscillator
  • RGEN 19.54
  • PEGA 84.26

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About PEGA Pegasystems Inc.

Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management with customer relationship management applications. The company focuses on enterprise-size customers in the financial, insurance, and healthcare industries.

Share on Social Networks: